Style | Citing Format |
---|---|
MLA | Yousefnia S, et al.. "Suppressive Role of Viola Odorata Extract on Malignant Characters of Mammosphere-Derived Breast Cancer Stem Cells." Clinical and Translational Oncology, vol. 22, no. 9, 2020, pp. 1619-1634. |
APA | Yousefnia S, Naseri D, Seyed Forootan F, Tabatabaeian M, Moattar F, Ghafghazi T, Nasr Esfahani MH, Ghaedi K (2020). Suppressive Role of Viola Odorata Extract on Malignant Characters of Mammosphere-Derived Breast Cancer Stem Cells. Clinical and Translational Oncology, 22(9), 1619-1634. |
Chicago | Yousefnia S, Naseri D, Seyed Forootan F, Tabatabaeian M, Moattar F, Ghafghazi T, Nasr Esfahani MH, Ghaedi K. "Suppressive Role of Viola Odorata Extract on Malignant Characters of Mammosphere-Derived Breast Cancer Stem Cells." Clinical and Translational Oncology 22, no. 9 (2020): 1619-1634. |
Harvard | Yousefnia S et al. (2020) 'Suppressive Role of Viola Odorata Extract on Malignant Characters of Mammosphere-Derived Breast Cancer Stem Cells', Clinical and Translational Oncology, 22(9), pp. 1619-1634. |
Vancouver | Yousefnia S, Naseri D, Seyed Forootan F, Tabatabaeian M, Moattar F, Ghafghazi T, et al.. Suppressive Role of Viola Odorata Extract on Malignant Characters of Mammosphere-Derived Breast Cancer Stem Cells. Clinical and Translational Oncology. 2020;22(9):1619-1634. |
BibTex | @article{ author = {Yousefnia S and Naseri D and Seyed Forootan F and Tabatabaeian M and Moattar F and Ghafghazi T and Nasr Esfahani MH and Ghaedi K}, title = {Suppressive Role of Viola Odorata Extract on Malignant Characters of Mammosphere-Derived Breast Cancer Stem Cells}, journal = {Clinical and Translational Oncology}, volume = {22}, number = {9}, pages = {1619-1634}, year = {2020} } |
RIS | TY - JOUR AU - Yousefnia S AU - Naseri D AU - Seyed Forootan F AU - Tabatabaeian M AU - Moattar F AU - Ghafghazi T AU - Nasr Esfahani MH AU - Ghaedi K TI - Suppressive Role of Viola Odorata Extract on Malignant Characters of Mammosphere-Derived Breast Cancer Stem Cells JO - Clinical and Translational Oncology VL - 22 IS - 9 SP - 1619 EP - 1634 PY - 2020 ER - |